Healthcare & Life Sciences
Acrivon
United Statesacrivon.com
Acrivon is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Acrivon
Acrivon is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Acrivon develops targeted precision oncology therapies by using its proprietary AP3 platform to match drug mechanisms to the biological drivers of cancer, focusing on kinase inhibitors and DNA damage response pathways, with several clinical-stage drug candidates.
Explore Acrivon's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.